MicroRNA basis of physiological hypertrophy

Frontiers in Genetics

Volumn 4, Issue NOV, 2013, Pages

  Fu, Siyi ^a   Zhuo, Ran ^a   Yao, Mengchao ^a   Zhang, Jiawen ^a   Zhou, Hanling ^a   Xiao, Junjie ^a  

^a SHANGHAI UNIVERSITY   (China)

Author keywords

Heart failure; microRNAs; Pathological hypertrophy; Physiological hypertrophy; Proliferation

Indexed keywords

EID: 84890307855     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00253     Document Type: Article

References (13)

1. Boström, P., Mann, N., Wu, J., Quintero, P. A., Plovie, E. R., Panáková, D., et al. (2010). C/EBPbeta controls exercise-induced cardiac growth andprotects against pathological cardiac remodeling. Cell 143, 1072-1083. doi: 10.1016/j.cell.2010.11.036.
2. Da Costa Martins, P. A., and De Windt, L. J. (2012). MicroRNAs in control of cardiac hypertrophy. Cardiovasc. Res. 93, 563-572. doi: 10.1093/cvr/cvs013.
3. Diniz, G. P., Takano, A. P., and Barreto-Chaves, M. L., (2013). MiRNA-208a and miRNA-208b are triggered in thyroidhormone-induced cardiac hypertrophy-role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/alpha-MHC modulation. Mol. Cell. Endocrinol. 374, 117-124. doi: 10.1016/j.mce.2013.04.010.
4. Ellison, G. M., Waring, C. D., Vicinanza, C., and Torella, D. (2012). Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 98, 5-10. doi: 10.1136/heartjnl-2011-300639.
5. Frey, N., Katus, H. A., Olson, E. N., and Hill, J. A., (2004). Hypertrophy of the heart: a new therapeutic target? Circulation 109, 1580-1589. doi: 10.1161/01.CIR.0000120390.68287.BB.
6. Kumarswamy, R., and Thum, T. (2013). Non-coding RNAs in cardiac remodeling and heart failure. Circ. Res. 113, 676-689. doi: 10.1161/CIRCRESAHA.113.300226.
7. Maillet, M., van Berlo, J. H., and Molkentin, J. D. (2013). Molecular basis of physiological heart growth: fundamental concepts and new players. Nat. Rev. Mol. Cell Biol. 14, 38-48. doi: 10.1038/nrm3495.
8. Rosenzweig, A. (2012). Medicine. Cardiac regeneration. Science 338, 1549-1550. doi: 10.1126/science.1228951.
9. Soci, U. P., Fernandes, T., Hashimoto, N. Y., Mota, G. F., Amadeu, M. A., Rosa, K. T., et al. (2011). MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol. Genomics 43, 665-673. doi: 10.1152/physiolgenomics.00145.
10. Waring, C. D., Vicinanza, C., Papalamprou, A., Smith, A. J., Purushothaman, S., Goldspink, D. F., et al. (2012). The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur. Heart J. doi: 10.1093/eurheartj/ehs338. [Epub ahead of print].
11. Xiao, J., Liang, D., Zhang, H., Liu, Y., Zhang, D., Liu, Y., et al. (2012). MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J. Mol. Cell. Cardiol. 53, 751-759. doi: 10.1016/j.yjmcc.2012.08.024.
12. Xiao, J., Liang, D., Zhang, Y., Liu, Y., Zhang, H., Liu, Y., et al. (2011). MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol. Genomics 43, 655-664. doi: 10.1152/physiolgenomics.00139.2010.
13. Xu, J., Zhao, J., Evan, G., Xiao, C., Cheng, Y., and Xiao, J. (2012). Circulating microRNAs: novel biomarkers for cardiovascular diseases. J. Mol. Med. (Berl.) 90, 865-875. doi: 10.1007/s00109-011-0840-5.